Professor Tania Dottorini is Professor of Artificial Intelligence for Science at King’s College London, based in the Department of Infectious Diseases, School of Immunology and Microbial Sciences, Faculty of Life Sciences & Medicine. Her research sits at the interface of artificial intelligence, genomics, and global health, with a particular focus on antimicrobial resistance (AMR) and infectious disease within a One Health framework. She develops and applies machine learning, multi-omics data integration, and large-scale genomic surveillance methods to understand how resistance and pathogens emerge, evolve, and spread across humans, animals, and environments. She is also active in the drug discovery across several WHO priority pathogens.s
Professor Dottorini has secured over £17 million in competitive research funding, more than three-quarters of it as Principal Investigator, from UKRI (MRC, BBSRC), EU Horizon, EDCTP, Innovate UK, and JPIAMR. Her recent leading projects include large-scale AI-driven AMR surveillance and forecasting initiatives spanning the UK, China, Bangladesh, and Sub-Saharan Africa. Her work has produced over 60 peer-reviewed publications, including in Cell Genomics, Nature Communications, Nature Food, Science, PNAS, and the ISME Journal, and her most recent study presents a multiscale machine-learning framework forecasting global antimicrobial resistance trends to 2050 across more than 45,000 bacterial genomes from 127 countries as well as in specific contexts such as the China food chain.
She has maintained a long-standing and productive collaboration with research institutions, government bodies, and industry in China, dating back to 2019, including as founder and Director of the Centre for Smart Food Research at the University of Nottingham Ningbo China and Head of the UK–Ningbo joint laboratory on AI-powered food safety and AMR early warning. She has a long-lasting collaboration with National Academy of Science and The Centre for food Safety and risk assessment. This partnership has produced multiple high-impact joint publications and has been recognised at government level, including her participation in a UK Foreign, Commonwealth & Development Office delegation to China and an invited presentation at the British Embassy in Beijing on UK–China cooperation in tackling antimicrobial resistance. Her work is focused on LMICs, with strong investment in Africa and South Asia.
Professor Dottorini serves on numerous international scientific advisory boards and funding panels, including UKRI, EU, NIHR, Human Frontiers Advisory Panel.
